Glycerophosphocholine Metabolites and Cardiovascular Disease Risk Factors in Adolescents: A Cohort Study

CirculationPublished Cross-sectional study

Authors' conclusion

We identified novel GPCs strongly associated with multiple CVD risk factors in adolescents.

Study context

Population
Adolescents (12–18 years, 48% male), Saguenay Youth Study69 serum glycerophosphocholine (GPCs) identified
Participants
990 adolescents
Outcome
Association of serum GPCs with CVD risk factors (excess visceral fat, elevated BP, insulin resistance, atherogenic dyslipidemia)
Methodological detailspopulation-based, targeted serum lipidomics, visceral fat (VF) measured with MRI, Liquid chromatography-electrospray ionization-mass spectrometry
  • Population-based
  • Targeted serum lipidomics
  • VF measured with MRI
  • Liquid chromatography-electrospray ionization-mass spectrometry

Main finding

As reported in the abstract

Associations of novel GPCs with CVD risk factors
PC16:0/2:0 negatively associated with VF
P=1.4×10-19
PC16:0/2:0 negatively associated with BP
P=7.7×10-5
PC16:0/2:0 negatively associated with fasting triacylglycerols
P=9.0×10-5
PC14:1/0:0 positively associated with VF
P=3.0×10-7
PC14:1/0:0 positively associated with fasting insulin
P=5.4×10-32
PC14:1/0:0 positively associated with triacylglycerols
P=1.4×10-29

Observational data: associations, not effects.

Further findings

Mediation of VF–cardiovascular disease (CVD) risk factor relations by GPCs (Sobel test)

Both GPCs mediated their respective relations between VF (exposure) and CVD risk factors (outcomes)
P < 1.3×10-3

PC18:2/0:0 (predicts incident CHD in older adults)

Associated with several CVD risk factors; less strong than newly identified GPCs

Original publication

Glycerophosphocholine Metabolites and Cardiovascular Disease Risk Factors in Adolescents: A Cohort Study. Circulation. Published 18 October 2016. doi:10.1161/circulationaha.116.022993

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.